Gene signature is associated with early stage rectal cancer recurrence

Journal of the American College of Surgeons

Volumn 211, Issue 2, 2010, Pages 187-195

  Kalady, Matthew F ^a   Dejulius, Kathryn ^a   Church, James M ^a   Lavery, Ian C ^a   Fazio, Victor W ^a   Ishwaran, Hemant ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RNA;

ACCURACY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; GENE EXPRESSION PROFILING; GENOME; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; RECURRENT CANCER; TUMOR GENE; COLON RESECTION; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RECTAL NEOPLASMS; TIME; TUMOR RECURRENCE;

AGED; COLECTOMY; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; RECTAL NEOPLASMS; RNA, NEOPLASM; ROC CURVE; TIME FACTORS;

EID: 77955559492     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2010.03.035     Document Type: Article

References (44)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA: Cancer J Clin 55 2005 74 108
2. I.C. Lavery, F. Lopez-Kostner, and V.W. Fazio Chances of cure are not compromised with sphincter-saving procedures for cancer of the lower third of the rectum Surgery 122 1997 779 784 discussion 784785
3. G. Steele Jr Adjuvant therapy for patients with colorectal cancer World J Surg 19 1995 241 245
4. K.D. Holen, and L.B. Saltz New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer Lancet Oncol 2 2001 290 297
5. D.H. Robbins, and S.H. Itzkowitz The molecular and genetic basis of colon cancer Medical Clin North Am 86 2002 1467 1495
6. A.M. Haydon, and J.R. Jass Emerging pathways in colorectal-cancer development Lancet Oncol 3 2002 83 88
7. S. Gill, N.M. Lindor, and L.J. Burgart Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation Clin Cancer Res 11 2005 6466 6471
8. J.E. Hardingham, W.J. Butler, and D. Roder Somatic mutations, acetylator status, and prognosis in colorectal cancer Gut 42 1998 669 672
9. J.M. Ferraz, F. Zinzindohoue, and T. Lecomte Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer Int J Cancer 110 2004 183 187
10. A. Russo, V. Bazan, and B. Iacopetta The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment J Clin Oncol 23 2005 7518 7528
11. G. Deng, I. Bell, and S. Crawley BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer Clin Cancer Res 10 2004 191 195
12. A. Lievre, J.B. Bachet, and D. Le Corre KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer Cancer Res 66 2006 3992 3995
13. D.C. Thomas, R.W. Haile, and D. Duggan Recent developments in genomewide association scans: a workshop summary and review Am J Hum Genet 77 2005 337 345
14. C. Jones, P. Simpson, and A. Mackay Expression profiling using cDNA microarrays Methods Mol Med 120 2006 403 414
15. D.J. Duggan, M. Bittner, and Y. Chen Expression profiling using cDNA microarrays Nat Genet 21 1 Suppl 1999 10 14 (Pubitemid 29031485)
16. A. Potti, S. Mukherjee, and R. Petersen A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer N Engl J Med 355 2006 570 580
17. A. Rosenwald, G. Wright, and W.C. Chan The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma N Engl J Med 346 2002 1937 1947
18. L.J. van 't Veer, H. Dai, and M.J. van de Vijver Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
19. Y. Wang, T. Jatkoe, and Y. Zhang Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer J Clin Oncol 22 2004 1564 1571
20. M. Dunning, M. Smith, and I. Camilier Beadarray: Quality control and low-level analysis of BeadArrays R package version 1.4.0 2007
21. H. Ishwaran, and J.S. Rao Detecting differentially expressed genes in microarrays using Bayesian model selection J Amer Stat Assoc 98 2003 438 455
22. H. Ishwaran, and J. Rao Spike and slab gene selection for multigroup microarray data J Amer Stat Assoc 100 2005 764 780
23. H. Ishwaran, J.S. Rao, and U.B. Kogalur BAMarraytrade mark: Java software for Bayesian analysis of variance for microarray data BMC Bioinformatics 7 2006 59
24. A. Papana, H. Ishwaran, and A. Papana CART variance stabilization and regularization for high-throughput genomic data Bioinformatics 22 2006 2254 2261
25. H. Ishwaran, and J.S. Rao Clustering gene expression profile data by selective shrinkage Stat Prob Letters 78 2008 1490 1497
26. R. Tibshirani, T. Hastie, and B. Narasimhan Diagnosis of multiple cancer types by shrunken centroids of gene expression Proc Natl Acad Sci USA 99 2002 6567 6572
27. T. Hastie, R. Tibshirani, and N. Narasimhan pamr: Pam: prediction analysis for microarrays R package version 1.31 2008
28. J. Murphy, M. Pocard, and J.R. Jass Number and size of lymph nodes recovered from Dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response Dis Colon Rectum 50 2007 1526 1534
29. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
30. Improved survival with preoperative radiotherapy in resectable rectal cancer Swedish Rectal Cancer Trial N Engl J Med 336 1997 980 987
31. J. Folkesson, H. Birgisson, and L. Pahlman Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate J Clin Oncol 23 2005 5644 5650
32. A. Hoos, A. Nissan, and A. Stojadinovic Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis Clin Cancer Res 8 2002 3841 3849
33. K. Kawakami, A. Ruszkiewicz, and G. Bennett DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer Br J Cancer 94 2006 593 598 (Pubitemid 43289765)
34. B.M. Ghadimi, M. Grade, and M.J. Difilippantonio Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy J Clin Oncol 23 2005 1826 1838
35. Y. Jiang, G. Casey, and I.C. Lavery Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer J Mol Diagn 10 2008 346 354
36. A. Barrier, A. Lemoine, and P.Y. Boelle Colon cancer prognosis prediction by gene expression profiling Oncogene 24 2005 6155 6164
37. M.F. Kalady, J.A. Sanchez, and E. Manilich Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas Dis Colon Rectum 52 2009 1039 1045
38. J. Quackenbush Microarray analysis and tumor classification N Engl J Med 354 2006 2463 2472
39. J. Thompson, W. Zimmermann, and P. Nollau CGM2, a member of the carcinoembryonic antigen gene family is down-regulated in colorectal carcinomas J Biol Chem 269 1994 32924 32931
40. S. Scholzel, W. Zimmermann, and G. Schwarzkopf Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas Am J Pathol 156 2000 595 605
41. H. Kim, H.J. Kang, and K.T. You Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival Proteomics 6 2006 3466 3476
42. H. Fischer, R. Stenling, and C. Rubio Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2 Carcinogenesis 22 2001 875 878
43. H. Fischer, S. Salahshor, and R. Stenling COL11A1 in FAP polyps and in sporadic colorectal tumors BMC Cancer 1 2001 17
44. T. Asano, M. Tada, and S. Cheng Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma J Surg Res 146 2008 32 42